-
Drugs that inhibit Cholesterol Ester Transfer Protein markedly increase levels of HDL cholesterol.
-
-
-
-
The Consumers Union in Washington, DC, has drafted the following model legislation designed for patient safety advocates to introduce in individual states as the Hospital Infections Disclosure Act. Highlights of the draft are summarized as follows in this article.
-
Arrow International (Reading, Pennsylvania) reported the promotion of several executives to positions of new responsibility and the retirement of Philip Fleck, president and chief operating officer, effective Dec. 31.
-
E-Z-EM (Lake Success, New York) reported that the spin-off of its AngioDynamics subsidiary has been completed. On Oct. 30, E-Z-EM distributed 0.856377 of a share of AngioDynamics common stock as a dividend on each outstanding share of E-Z-EM common stock to E-Z-EM shareholders of record as of Oct. 11. E-Z-EM shareholders received cash in lieu of any fractional shares.
-
Eric Topol, MD, chief academic officer of the Cleveland Clinic, said during the Clinic-sponsored Medical Innovation Summit here in mid-October that those involved with or interested in innovation need to get away from the idea that every drug and device needs to be a blockbuster product.
-
-
